Randomized phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2012
At a glance
- Drugs Cisplatin; Docetaxel; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 15 Dec 2008 Actual patient number identified as 88 from ClinicalTrials.gov.
- 15 Dec 2008 Actual trial completion date identified as August 2008 from ClinicalTrials.gov.
- 15 Dec 2008 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History